Eli Lilly has selected a leading USA-approved GMP manufacturer to produce its groundbreaking medications, Retatrutide and Tirzepatide. This strategic decision emphasizes Lilly's commitment to excellence in manufacturing and guarantees patients with access to safe and potent treatments. The chosen partner possesses a strong track record of adherence